4BASEBIO UK SOCIETAS (4BB)

Currency in GBP
965.00
0.00(0.00%)
Closed·
4BB Scorecard
Full Analysis
Holds more cash than debt on its balance sheet
4BB is not included in our AI-picked strategies. See which stocks are.
Fair Value
Day's Range
965.00979.00
52 wk Range
940.001,550.00
Key Statistics
Bid/Ask
920.00 / 1,000.00
Prev. Close
965
Open
965
Day's Range
965-979
52 wk Range
940-1,550
Volume
408
Average Volume (3m)
1.24K
1-Year Change
-34.58%
Fair Value
unlockUnlock
Fair Value Upside
unlockUnlock
4BB Scorecardpro icon
Company’s Health
Unlock
Fair Value
Unlock Price
Fair Price
Upside
Price Target
1,700.00
Upside
+76.17%
Members' Sentiments
Bearish
Bullish
ProTips
Analysts anticipate sales growth in the current year

4BASEBIO UK SOCIETAS News & Analysis

Show more

Technical Analysis

Summary
Strong Sell
Sell
Neutral
Buy
Strong Buy
Strong Sell
Technical Indicators
Strong Sell
Moving Averages
Sell

4BASEBIO UK SOCIETAS Company Profile

4basebio PLC, together with its subsidiaries, engages in the research, development, manufacturing, and commercialization of synthetic DNA and RNA products, and non-viral vector solutions in Europe, the United States, and internationally. The company offers hpDNA, double stranded linear DNA, covalently closed with single strand hairpins at the 5’ and 3’ ends for viral and non-viral vector applications; opDNA, a partially opened, linear, double stranded DNA product for in vitro transcription processes for the production of mRNA for use in vaccines and therapeutics; and oeDNA, or open ended DNA, a linear, double stranded DNA product ideal for genome editing. It also provides osDNA, or open stabilized DNA, a product incorporating nucleotide modifications within the DNA backbone enables tuning of the immunostimulatory properties of the construct for DNA vaccine applications; and The Hermes, a proprietary delivery platform for nucleic acid and protein payloads appears to offer a thermo-stable alternative to traditional lipid based delivery systems. The company was formerly known as 4basebio UK Societas and changed its name to 4basebio PLC in July 2021. 4basebio PLC was founded in 2008 and is based in Cambridge, the United Kingdom.

Compare 4BB to Peers and Sector

Metrics to compare
4BB
Peers
Sector
Relationship
P/E Ratio
−12.1x−5.8x−0.5x
PEG Ratio
0.24−0.020.00
Price/Book
5.7x1.2x2.6x
Price / LTM Sales
160.1x10.8x3.2x
Upside (Analyst Target)
76.2%154.2%42.7%
Fair Value Upside
Unlock−1.9%5.8%Unlock

Analyst Ratings

1 Buy
0 Hold
0 Sell
Ratings:
1 analysts
Overall Consensus
Buy

Analysts 12-Month Price Target:

Average 1,700.00
(+76.17% Upside)

Earnings

Latest Release
May 07, 2025
EPS / Forecast
-0.52 / --
Revenue / Forecast
605.00K / --
EPS Revisions
Last 90 days

4BB Income Statement

FAQ

What Stock Exchange Does 4BASEBIO UK SOCIETAS Trade On?

4BASEBIO UK SOCIETAS is listed and trades on the London Stock Exchange stock exchange.

What Is the Stock Symbol for 4BASEBIO UK SOCIETAS?

The stock symbol for 4BASEBIO UK SOCIETAS is "4BB."

What Is the 4BASEBIO UK SOCIETAS Market Cap?

As of today, 4BASEBIO UK SOCIETAS market cap is 149.36M.

What Is 4BASEBIO UK SOCIETAS's Earnings Per Share (TTM)?

The 4BASEBIO UK SOCIETAS EPS (TTM) is -0.94.

When Is the Next 4BASEBIO UK SOCIETAS Earnings Date?

4BASEBIO UK SOCIETAS will release its next earnings report on 25 Sept 2025.

From a Technical Analysis Perspective, Is 4BB a Buy or Sell?

Based on moving averages and other technical indicators, the daily buy/sell signal is Strong Sell.

How Many Times Has 4BASEBIO UK SOCIETAS Stock Split?

4BASEBIO UK SOCIETAS has split 0 times.

How Many Employees Does 4BASEBIO UK SOCIETAS Have?

4BASEBIO UK SOCIETAS has 110 employees.

What is the current trading status of 4BASEBIO UK SOCIETAS (4BB)?

As of 23 Jul 2025, 4BASEBIO UK SOCIETAS (4BB) is trading at a price of 965.00, with a previous close of 965.00. The stock has fluctuated within a day range of 965.00 to 979.00, while its 52-week range spans from 940.00 to 1,550.00.
Risk Disclosure: Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers
© 2007-2025 - Fusion Media Limited. All Rights Reserved.